Role of TRP ion channels in cancer and tumorigenesis

George Shapovalov1,2, Abigael Ritaine1,2, Roman Skryma1,2

  • 1Inserm U1003, Equipe Labellisee par la Ligue Nationale Contre le Cancer, Universite de Sciences et Technologies de Lille (USTL), F-59655, Villeneuve d'Ascq, France.

Insights

Transient receptor potential (TRP) channels regulate cell fate and calcium (Ca2+) homeostasis. Dysregulation of TRP channels contributes to cancer development by altering cell survival, proliferation, and invasion.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Transient receptor potential (TRP) channels are a family of calcium-permeable ion channels sensitive to environmental factors.
  • TRP channels play critical roles in regulating intracellular calcium (Ca2+) distribution and cellular processes.
  • Dysregulation of TRP channels is implicated in the development of various diseases, including cancer.

Purpose of the Study:

  • To review the current scientific understanding of TRP channel involvement in cell fate regulation.
  • To highlight the role of TRP channels in cancer development and progression.
  • To discuss the contribution of TRP channels to cellular processes controlling cell fate in transformed tissues.

Main Methods:

  • Literature review of accumulated scientific knowledge on TRP channels and cancer.
  • Analysis of studies focusing on TRP channel function in cell fate regulation.
  • Synthesis of information regarding the impact of TRP channel dysregulation on cancer hallmarks.

Main Results:

  • TRP channels are crucial regulators of cellular calcium homeostasis.
  • Mutations or altered expression of TRP channels disrupt normal Ca2+ signaling.
  • Distorted Ca2+ patterns due to TRP channel dysregulation promote cancer hallmarks like enhanced survival, proliferation, and invasion.

Conclusions:

  • TRP channels are significant regulators of cell fate.
  • TRP channels are important players in cancer development and progression.
  • Targeting TRP channels may offer therapeutic strategies for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K